Overview

Adjunctive Glycine for Obsessive Compulsive Disorder

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.
Phase:
N/A
Details
Lead Sponsor:
Nathan Kline Institute for Psychiatric Research
Collaborator:
Obsessive Compulsive Foundation
Treatments:
Glycine